How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

All the Latest Game Footage and Images from Maze Keeper You are the guardian of a cursed labyrinth and must prevent an adventurer from escaping with the help of your monsters. But the adventurer keeps ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.

Recursion Pharmaceuticals reported mixed Q2 results, with revenue declining to $7.67 million and a net loss of $131.01 million. Despite setbacks, advancements in clinical trials and partnerships with ...